IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $383,247 | +1.8% | 8,449 | -7.9% | 0.00% | – |
| Q2 2023 | $376,286 | +1.2% | 9,171 | -11.8% | 0.00% | – |
| Q1 2023 | $371,696 | -28.3% | 10,400 | -24.2% | 0.00% | – |
| Q4 2022 | $518,166 | +4.3% | 13,719 | +21.9% | 0.00% | – |
| Q3 2022 | $497,000 | +138.9% | 11,251 | +205.6% | 0.00% | – |
| Q4 2020 | $208,000 | -98.2% | 3,682 | -98.5% | 0.00% | -100.0% |
| Q3 2020 | $11,500,000 | -21.1% | 242,351 | +0.9% | 0.01% | -25.0% |
| Q2 2020 | $14,575,000 | +28.1% | 240,230 | -0.2% | 0.01% | 0.0% |
| Q1 2020 | $11,379,000 | -28.5% | 240,673 | -8.7% | 0.01% | 0.0% |
| Q4 2019 | $15,924,000 | +0.8% | 263,600 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $15,792,000 | -6.8% | 263,600 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $16,942,000 | -50.1% | 263,600 | -36.9% | 0.01% | -50.0% |
| Q1 2019 | $33,929,000 | +320.7% | 418,000 | +180.2% | 0.02% | +260.0% |
| Q4 2018 | $8,065,000 | -68.1% | 149,180 | -69.6% | 0.01% | -61.5% |
| Q3 2018 | $25,303,000 | -15.3% | 490,574 | -31.6% | 0.01% | -13.3% |
| Q2 2018 | $29,878,000 | -8.4% | 717,016 | -3.1% | 0.02% | -11.8% |
| Q1 2018 | $32,608,000 | -13.6% | 739,756 | -1.5% | 0.02% | -5.6% |
| Q4 2017 | $37,759,000 | -19.7% | 750,666 | -19.0% | 0.02% | -21.7% |
| Q3 2017 | $46,997,000 | -8.9% | 926,968 | -8.6% | 0.02% | -11.5% |
| Q2 2017 | $51,586,000 | +19.9% | 1,014,064 | -5.2% | 0.03% | +18.2% |
| Q1 2017 | $43,015,000 | -16.6% | 1,070,034 | -0.6% | 0.02% | -18.5% |
| Q4 2016 | $51,573,000 | +34.1% | 1,076,534 | +2.6% | 0.03% | +35.0% |
| Q3 2016 | $38,464,000 | +52.3% | 1,049,714 | -3.2% | 0.02% | +42.9% |
| Q2 2016 | $25,253,000 | -64.8% | 1,084,367 | -38.8% | 0.01% | -63.2% |
| Q1 2016 | $71,743,000 | -35.3% | 1,771,447 | -1.1% | 0.04% | -32.1% |
| Q4 2015 | $110,964,000 | – | 1,791,747 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |